β-Defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 8054-8060

  Wu, Minhao ^a   McClellan, Sharon A ^a   Barrett, Ronald P ^a   Zhang, Yunfan ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; GAMMA INTERFERON; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BETA DEFENSIN; BETA DEFENSIN 3, MOUSE; BETA-DEFENSIN 3, MOUSE; DEFB2 PROTEIN, MOUSE; DEFB4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA STROMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFECTION RESISTANCE; KERATITIS; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; DRUG POTENTIATION; GENE SILENCING; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION;

ANIMALS; BETA-DEFENSINS; DRUG SYNERGISM; FEMALE; GENE SILENCING; IMMUNITY, INNATE; KERATITIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 76249084929     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902140     Document Type: Article

References (41)

1. Hazlett, L. D. 2004. Corneal response to Pseudomonas aeruginosa infection. Prog. Retin. Eye Res. 23: 1-30.
2. Hazlett, L. D., S. McClellan, B. Kwon, and R. Barrett. 2000. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest. Ophthalmol. Visual Sci. 41: 805-810.
3. Tomita, T., and T. Nagase. 2001. Defensins as a mechanism of host defense and innate immunity. Nippon Ronen Igakkai Zasshi 38: 440-443.
4. McDermott, A. M. 2004. Defensins and other antimicrobial peptides at the ocular surface. Ocul. Surf. 2: 229-247.
5. McDermott, A. M. 2009. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 41(2): 60-75.
6. Bals, R., M. J. Goldman, and J. M. Wilson. 1998. Mouse β-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect. Immun. 66: 1225-1232.
7. Morrison, G. M., D. J. Davidson, and J. R. Dorin. 1999. A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett. 442: 112-116.
8. Bals, R., X. Wang, R. L. Meegalla, S. Wattler, D. J. Weiner, M. C. Nehls, and J. M. Wilson. 1999. Mouse 7beta;-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect. Immun. 67: 3542-3547.
9. Chong, K. T., R. R. Thangavel, and X. Tang. 2008. Enhanced expression of murine β-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice. Virology. 380: 136-143.
10. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298: 1025-1029. (Pubitemid 35247310)
11. Wu, M., S. A. McClellan, R. P. Barrett, and L. D. Hazlett. 2009. β-Defensin-2 promotes resistance against infection with P. aeruginosa. J. Immunol. 182: 1609-1616.
12. Schröder, J. M., and J. Harder. 1999. Human β-defensin-2. Int. J. Biochem. Cell Biol. 31: 645-651.
13. Feng, Z., B. Jiang, J. Chandra, M. Ghannoum, S. Nelson, and A. Weinberg. 2005. Human β-defensins: differential activity against candidal species and regulation by Candida albicans. J. Dent. Res. 84: 445-450.
14. García, J. R., F. Jaumann, S. Schulz, A. Krause, J. Rodríguez-Jiménez, U. Forssmann, K. Adermann, E. Klüver, C. Vogelmeier, D. Becker, et al. 2001. Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306: 257-264.
15. Niyonsaba, F., K. Iwabuchi, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. Epithelial cell-derived human β-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 14: 421-426.
16. Chen, X., F. Niyonsaba, H. Ushio, D. Okuda, I. Nagaoka, S. Ikeda, K. Okumura, and H. Ogawa. 2005. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40: 123-132.
17. + T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J. Immunol. 159: 6283-6290.
18. Hazlett, L. D., M. M. Moon, M. Strejc, and R. S. Berk. 1987. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest. Ophthalmol. Vis. Sci. 28: 1978-1985.
19. Nakamura, H., S. S. Siddiqui, X. Shen, A. B. Malik, J. S. Pulido, N. M. Kumar, and B. Y. Yue. 2004. RNA interference targeting transforming growth factor-β type II receptor suppresses ocular inflammation and fibrosis. Mol. Vis. 10: 703-711.
20. Huang, X., R. P. Barrett, S. A. McClellan, and L. D. Hazlett. 2005. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 46: 4209-4216.
21. Kleinman, M. E., K. Yamada, A. Takeda, V. Chandrasekaran, M. Nozaki, J. Z. Baffi, R. J. Albuquerque, S. Yamasaki, M. Itaya, Y. Pan, et al. 2008. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597.
22. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994.
23. Roux, K. H. 1995. Optimization and troubleshooting in PCR. PCR Methods Appl. 4: 185-194.
24. Williams, R. N., C. A. Paterson, K. E. Eakins, and P. Bhattacherjee. 1982. Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr. Eye Res. 2: 465-470.
25. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schröder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
26. McClellan, S. A., S. Lighvani, and L. D. Hazlett. 2006. IFN-γ: regulation of nitric oxide in the P. aeruginosa-infected cornea. Ocul. Immunol. Inflamm. 14: 21-28.
27. Radhakrishnan, S., K. R. Wiehagen, V. Pulko, V. Van Keulen, W. A. Faubion, K. L. Knutson, and L. R. Pease. 2007. Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-γ. J. Immunol. 178: 3583-3592.
28. Sekiya, M., M. Adachi, S. Takayama, J. C. Reed, and K. Imai. 1997. IFN-γ upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells. Biochem. Biophys. Res. Commun. 239: 401-406.
29. Yu, F. S., and L. D. Hazlett. 2006. Toll-like receptors and the eye. Invest. Ophthalmol. Vis. Sci. 47: 1255-1263.
30. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
31. Esen, N., and T. Kielian. 2006. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. J. Immunol. 176: 6802-6811. (Pubitemid 43787863)
32. Matsumoto, K., K. Ikema, and H. Tanihara. 2005. Role of cytokines and chemokines in pseudomonal keratitis. Cornea 24(8 Suppl.): S43-S49. (Pubitemid 41688555)
33. Hazlett, L. D. 2005. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul. Immunol. Inflamm. 13: 133-138.
34. Zhao, J., H. J. Kong, H. Li, B. Huang, M. Yang, C. Zhu, M. Bogunovic, F. Zheng, L. Mayer, K. Ozato, et al. 2006. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-γ signaling pathways. J. Biol. Chem. 281: 10073-10080.
35. Burd, R. S., J. L. Furrer, J. Sullivan, and A. L. Smith. 2002. Murine β-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock 18: 461-464.
36. Marrero, M. B., V. J. Venema, H. He, R. B. Caldwell, and R. C. Venema. 1998. Inhibition by the JAK/STAT pathway of IFNγ- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 252: 508-512.
37. Lai, Y., and R. L. Gallo. 2009. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30: 131-141.
38. da Silva Correia, J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-21135.
39. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173: 17-26.
40. Hazlett, L. D., S. McClellan, C. Goshgarian, X. Huang, A. Thakur, and R. Barrett. 2005. The role of nitric oxide in resistance to P. aeruginosa ocular infection. Ocul. Immunol. Inflamm. 13: 279-288.
41. Yang, D., A. Biragyn, D. M. Hoover, J. Lubkowski, and J. J. Oppenheim. 2004. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22: 181-215.